Ravi Salgia to Drug Resistance, Multiple
This is a "connection" page, showing publications Ravi Salgia has written about Drug Resistance, Multiple.
Connection Strength
0.019
-
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma. Cancer Chemother Pharmacol. 2008 Apr; 61(4):549-58.
Score: 0.019